Navigation Links
Biomatrica Announces the Appointment of Dr. James A. Robb as a Member of the Scientific Advisory Board
Date:5/26/2011

SAN DIEGO, May 26, 2011 /PRNewswire/ -- Biomatrica, Inc., the leader in room temperature sample storage and stabilization, today announced the appointment of Dr. James A. Robb to the Scientific Advisory Board.

Dr. Robb is a well respected pathologist and scientist with over 45 years experience in the fields of molecular pathology, virology, and genetics. He currently serves as a Governor of the College of American Pathologists, an organization consisting of over 18,000 board-certified pathologists, and for the past few years has been a SAIC-Frederick Consulting Pathologist in the Office of Biorepositories and Biospecimen Research (OBBR), National Cancer Institute, NIH. Dr. Robb also served on the Secretary of Health and Human Services' Committee for Genetics, Health and Society Task Force on Oversight of Genetic Tests.  Dr. Robb received his M.D. (cum laude) from the University of Colorado in 1965, and completed his pathology residency and molecular biology training at Yale University, before becoming a Senior Surgeon at NIH. After NIH, he moved to the Department of Pathology, University of California San Diego (UCSD), becoming a tenured Professor of Pathology before taking the position of staff pathologist and director of molecular pathology and cytopathology at Scripps Clinic, La Jolla, CA. He then helped develop, and then became Medical Director of the HCA East Florida Division's Integrated Regional Laboratories.

"Since being introduced to Biomatrica technology, it has become apparent to me how critical this technology is to the future of personalized medicine and global health care initiatives. As a long-term participant and policy maker in the collection, annotation, processing, storage and clinical testing of biospecimens, I am fully aware of the need to protect and better manage these critical samples, especially as we transition into the era of personalized molecular, genomically informed medicine," says Dr. Robb. "We are in need of new technologies that deliver significant cost savings, superior logistics to cold handling and storage, without compromising biospecimen quality and integrity. All of these benefits are found in the technologies that have been and are being developed at Biomatrica, and I am delighted to serve on the company's Scientific Advisory Board."  

"Biomatrica is proud to have Dr. Robb join our SAB team bringing a wealth of experience, expertise and knowledge in clinical and molecular diagnostics for disease management and stratification," says Dr. Rolf Muller, Biomatrica's Chief Scientific Officer, President and Founder. "Dr. Robb will play a key role in helping Biomatrica chart a new course with new technologies under development designed for efficient management of critical biological samples for use in clinical trials, diagnostics, biobanking, genomics research, as well as forensic investigations. With Jim joining our SAB, we believe that Biomatrica is primed to become the leader in ambient stabilization for all biosamples and create the types of solutions that support and enhance better management of samples for advancing globalized health care and personalized medicine."

About Biomatrica, Inc.

Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing, shipping and assaying biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA and RNA with no sample degradation, thus labs can reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types such as proteins are also available. Biomatrica also offers SampleWare® software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology. For more information about the SampleMatrix technology and the Biomatrica products utilizing this technology platform (DNAstable® and DNAgard™ for DNA, RNAstable® for RNA and CloneStable® for bacterial DNA), visit: http://www.biomatrica.com/ or call 1-866-379-6879.


'/>"/>
SOURCE Biomatrica
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Biomatrica Launches New Partnership Program - Biomatrica Connect(TM)
2. Biomatrica Launches SampleWare 3.1
3. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
4. Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan
5. Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage
6. Sequenom Announces Participation at Jefferies 2011 Global Healthcare Conference
7. WaferGen Announces $30 Million Financing
8. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
9. Vermillion Announces Notice of Allowance for Alzheimer Patent
10. VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
11. Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 For today, Stock-Callers.com ... novel drug development and clinical research aimed at treating diseases ... (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. ... ). You can access our complimentary research reports on these ... ...
(Date:4/19/2017)... , ... April 19, 2017 , ... Nobilis Therapeutics ... , Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder ... of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic ...
(Date:4/19/2017)... Calif. , April 19, 2017  As ... Drug Abuse and Heroin Summit ,  Proove┬« Biosciences, ... study analyzing genetics, environmental, and lifestyle factors to ... from the University of Southern California (USC), the ... , and Proove publish results showing that Proove ...
(Date:4/18/2017)... ... April 18, 2017 , ... CallTower, an ... Next-Gen Solution Provider. , Channel Partners program recognizes IT and telecom channel leaders ... and advocacy of the channel during transition and convergence. CallTower is the first ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):